Eric Kmiec, CEO of CorriXR Therapeutics, was named to the Delaware Business Times 222 List, recognizing influential leaders shaping the state’s business community. This marks the third consecutive year Eric has received the honor. This recognition highlights his leadership and reflects CorriXR’s continued growth and influence in biotechnology.
Read more here.